sentences:
Association between asthma and suicidality in 9-11-year-old children BackgroundSuicidal thoughts and behavior (STB) in children are a growing health concern, and more data is needed regarding their biological underpinnings. Immune processes such as inflammation have been associated with STB, primarily in adults. Asthma is a common chronic inflammatory disorder in children and has been associated with STB in adolescent and adult populations, but data in children is lacking. We wished to study associations of asthma with childhood STB given asthmas potential as a clinically relevant model for childhood chronic immune dysregulation.

MethodsUsing data from the Adolescent Brain Cognitive Development (ABCD) Study (N=11,878, 52% males, mean age 9.9 years at baseline assessment and 10.9 years at 1-year follow up), we assessed associations between asthma and STB at both baseline and 1-year follow up.

ResultsWe found that asthma at baseline assessment (n=2,214, 18.6%) is associated with STB, controlling for multiple confounders including demographics, socioeconomic factors and environmental confounders such as air pollution (odds ratio (OR)=1.2, 95%CI 1.01-1.42, P=0.039). Indicators of recently active asthma were not significantly associated with suicidality at baseline assessment (currently taking asthma medication: OR=1.22, 95%CI 0.93-1.60, P=0.146), or at 1-year follow up (past year asthma-related clinical visit: OR=1.13, 95%CI 0.87-1.47, P=0.357). Proxy-measures of asthma severity (number of asthma medications or clinical visits) did not reveal a significant dose response relationship with STB.

ConclusionsFindings suggest an association between history of asthma and STB in children, which may not be related to asthma disease state. Further research is needed to investigate mechanisms underlying this relationship.

labels: psychiatry and clinical psychology


sentences:
A biological variation-based approach to the day-to-day changes of D-dimer, Fibrinogen, and Ferritin levels that are crucial in the clinical course of COVID-19 in healthy smokers and non-smokers ObjectiveD-dimer, ferritin, and fibrinogen parameters in COVID-19 patients are essential, particularly in inpatients and intensive care unit patients. It is vital to know the changes that occur due to the biological structure of the person than the disease effect in these tests in order to manage the fatal disease better.

MethodBlood samples were taken on the first, third, and fifth days from 30 healthy volunteers, 15 of whom were smokers, 15 were non-smokers, and D-dimer, ferritin, and fibrinogen tests were studied with repeated measurements. After the data processed for normality and homogeneity and removing extreme values, CVA, CVI, CVG, CVT, RCV, II, I%, B%, TE% values were calculated via a full nested ANOVA design, according to Callum G, Fraser, and EFLM.

ResultsCVI and CVG values of D-dimer were calculated as 49.07% and 40.69% for all individuals, 49.26% and 27.71% for smokers, 48.80% and 51.67% for non-smokers, respectively. In terms of fibrinogen, the same analyzes for all individuals were calculated as 11.18% and 10.62%, 3.25% and 20.17% for smokers, 9.11% and 6.79% for non-smokers, respectively. The same analyzes for ferritin were calculated as 23.74% and 63.31% for all individuals, 34.98% and 35.24% for smokers, 30.53% and 74.87% for non-smokers, respectively.

ConclusionChanges in D-dimer measurements every other day in healthy individuals can be observed depending on the biological characteristics of the individuals, and the population-based reference interval may be insufficient for clinical evaluation. Each individual should be evaluated within himself/herself. When evaluating the results of ferritin and fibrinogen in non-smoking individuals, it should be taken into account that significant differences may occur between individuals. Besides, it should be kept in mind that there may be significant changes due to biological variation in the repeated measurements of ferritin every other day.

labels: public and global health


sentences:
COVID-19 testing and vaccine willingness: Cross-sectional survey in a culturally diverse community in Sydney, Australia ObjectiveThe current study examined patterns in COVID-19 testing and vaccination intentions across multiple language groups in Greater Western Sydney, Australia.

MethodsParticipants completed a cross-sectional survey available from March 21 to July 9, 2021 in Sydney, Australia. Surveys were available in English or translated (11 languages). Participants could complete surveys independently or with support from bilingual staff. Logistic regression models using post-stratification weighted frequencies identified factors associated with testing and vaccination intentions.

ResultsMost of the 708 participants (88%, n=622) were not born in Australia; 31% reported that they did not speak English well or at all (n=220); 70% had no tertiary qualifications (n=497); and 41% had inadequate health literacy (n=290). Most participants reported high testing intention (77.2%, n=546), with differences observed across language groups (p<0.001). The most frequently reported barrier to testing was concerns about infection at the clinic (26.1%). Half (53.0%) reported willingness to get a COVID-19 vaccine if recommended to them (n=375); 18% were unwilling (n=127), and the remainder unsure (29%, n=205). These proportions varied significantly by language group (p<0.001). Participants were more likely to be unwilling/hesitant if they were female (p=0.02) or did not use Australian commercial information sources (p=0.01). Concerns about side effects (30.4%, n=102) and safety (23.9%, n=80), were key reported barriers to vaccination.

ConclusionDifferent language groups have unique and specific needs to support uptake of COVID-19 testing and vaccination. Health services must work collaboratively with culturally and linguistically diverse communities to provide tailored support to encourage COVID-19 testing and vaccination.

Lay summaryO_LI708 adults living in Sydney, Australia, who did not speak English as their main language at home took part in a survey about COVID-19 vaccination and testing.
C_LIO_LIParticipants could complete the survey online (English/translated) or with support from bilingual staff. The survey was available in 11 languages.
C_LIO_LIThree quarters of participants (77%) reported they would get tested for COVID-19 if they had symptoms  no matter what. The most common barrier was concern about getting infected at the testing clinic.
C_LIO_LI53% of participants reported that they would get a COVID-19 vaccine if it was recommended to them. 18% reported that they wouldnt get the vaccine, and 29% were unsure. The main barriers were concerns about vaccine side effects and safety.
C_LIO_LIIntentions to get tested for COVID-19 or to get vaccinated varied significantly across language groups. Participants who were female, or who did not use Australian commercial information sources were more likely to be unwilling or unsure about getting a COVID-19 vaccine.
C_LIO_LIDifferent language groups have unique and specific needs to support uptake of COVID-19 testing and vaccination. Health services must work collaboratively with culturally and linguistically diverse communities to provide tailored support to encourage COVID-19 testing and vaccination.
C_LI


sentences:
Orang Asli Health and Lifeways Project (OA HeLP): Study Protocol IntroductionNon-communicable disease (NCD) risk is influenced by environmental factors that are highly variable worldwide, yet prior research has focused mainly on high-income countries where most people are exposed to relatively homogenous and static environments. Understanding the scope and complexity of environmental influences on NCD risk around the globe requires more data from people living in diverse and changing environments. Our project will investigate the prevalence and environmental causes of NCDs among the indigenous peoples of Peninsular Malaysia, known collectively as the Orang Asli, who are currently undergoing varying degrees of lifestyle and sociocultural changes that are predicted to increase vulnerability to NCDs, particularly metabolic disorders and musculoskeletal degenerative diseases.

MethodsBiospecimen sampling and screening for a suite of NCDs (e.g., cardiovascular disease, type II diabetes, osteoarthritis, osteoporosis), combined with detailed ethnographic work to assess key lifestyle and sociocultural variables (e.g., diet, physical activity, technology usage), will take place in Orang Asli communities spanning a gradient from remote, traditional villages to acculturated, market-integrated urban areas. Analyses will, first, test for relationships between environmental variables, NCD risk factors, and NCD occurrence to investigate how environmental changes are affecting NCD susceptibility among the Orang Asli. Second, we will examine potential molecular and physiological mechanisms (e.g., epigenetics, systemic inflammation) that mediate environmental effects on health. Third, we will identify intrinsic (e.g., age, sex) and extrinsic (e.g., early life experiences) factors that predispose certain people to NCDs in the face of environmental change to better understand which Orang Asli individuals are at greatest risk of NCDs.

EthicsApproval was obtained from multiple ethical review boards including a committee at the Malaysian Ministry of Health. This study follows established principles for ethical biomedical research among vulnerable indigenous communities, including fostering collaboration, building cultural competency, enhancing transparency, supporting capacity building, and disseminating research findings.

Strengths and Limitations of This StudyO_LIEnvironmental influences on non-communicable disease (NCD) risk are understudied outside of high-income countries, particularly among societies transitioning from traditional, non-industrial lifestyles to market-integrated, urban lifestyles.
C_LIO_LIThis multidisciplinary project aims to better understand how rapid lifestyle and sociocultural changes are affecting NCD risk among the indigenous peoples of Peninsular Malaysia, known collectively as the Orang Asli.
C_LIO_LIMore broadly, this project aims to provide insights useful for understanding the rising prevalence of NCDs in other low- and middle-income countries and societies experiencing rapid environmental changes.
C_LIO_LIThis project might be limited by the SARS-CoV-2 pandemic.
C_LI


sentences:
Robotic walking for recovery of functional capacity in individuals with incomplete spinal cord injury: A randomized pilot trial ObjectiveActivity-based Training (ABT) represents the current standard of neurological rehabilitation. Robotic Locomotor Training (RLT) is an innovative technique that aims to enhance rehabilitation outcomes, however, its efficacy in SCI rehabilitation, particularly within a low-middle income setting, is currently unclear. The primary aim of this study was to determine the feasibility of a locomotor training program within XX, in terms of recruitment, attendance, drop-out rates and safety. Secondary aims were to determine the effects of RLT compared to ABT on functional capacity in people with chronic SCI.

DesignParticipants with chronic traumatic motor incomplete tetraplegia (n = 16) were recruited. Each intervention involved 60-minute sessions, 3x per week, over 24-weeks. RLT involved walking in the Ekso GT suit. ABT involved a combination of resistance, cardiovascular and weight-bearing exercise. Primary feasibility outcomes included recruitment rate, adherence rate, and adverse events. Validated tests were performed at baseline, 6, 12 and 24-weeks to assess the secondary outcomes of functional capacity.

ResultsOut of 110 individuals who expressed interest in participating in the study, 17 initiated the program (recruitment rate = 15.4 %). Of these, 16 individuals completed the program (drop-out rate = 5.8 %) and attended sessions (attendance rate = 93.9%). There were no significant differences between the intervention groups for lower or upper extremity motor scores (UEMS effect size (ES) = 0.09; LEMS ES = 0.05), back strength (ES = 0.14) and abdominal strength (ES = 0.13) after training. However, both groups showed a significant increase of 2.00 points in UEMS and a significant increase in abdominal strength from pre- to post intervention. Only the RLT group showed a significant change in LEMS, with a mean increase of 3.00 [0.00; 16.5] points over time. Distance walked in the Functional Ambulatory Inventory (SCI-FAI) increased significantly (p = 0.02) over time only for the RLT group.

ConclusionsRecruitment, attrition and adherence rates of the intervention and outcomes justify a subsequent powered RCT comparing RLT to ABT as an effective rehabilitation tool for potentially improving functional strength and walking capacity in people with incomplete SCI.

labels: rehabilitation medicine and physical therapy


sentences:
Virtual reality exercise to help COVID patients with refractory breathlessness BackgroundImmersive virtual reality (iVR)-based digital therapeutics (DTx) are gaining clinical attention in the field of pain management. Based on known analogies between pain and dyspnea, we investigated the effects of visual-respiratory feedback, on persistent dyspnea in patients recovering from COVID-19 pneumonia.

MethodsWe performed a controlled, randomized, single-blind, cross-over clinical study to evaluate an iVR-based intervention to alleviate dyspnea in patients recovering from COVID-19 pneumonia. Included patients reported persistent dyspnea ([≥]5 on a 10-point scale) and preserved cognitive function (MoCA>24). Assignment was random and concealed. Patients received synchronous (intervention) or asynchronous (control) feedback of their breathing, embodied via a gender-matched virtual body. Outcomes were assessed using questionnaires and breathing recordings. COVVR is registered with ClinicalTrials.gov (NCT04844567).

FindingsStudy enrollment was open between November 2020 and April 2021. Twenty-six patients were enrolled (27% women; age: median=55, interquartile range (IQR)=18). Data were available for 24 of 26 patients. The median (IQR) rating on a 7-point Likert-scale of breathing comfort improved from 1(2) at baseline, to 2(1) for synchronous feedback, but remained unchanged at 1(1.5) for asynchronous feedback (p<0.05) between iVR conditions). Moreover, 91.2% of all patients were satisfied with the intervention (p<0.0001) and 66.7% perceived it as beneficial for their breathing (p<0.05). No adverse events were reported.

InterpretationBased on these findings, our iVR-based DTx presents a feasible and safe respiratory rehabilitation tool that improves breathing comfort in patients recovering from COVID-19 infection presenting with persistent dyspnea. Future research should investigate the DTxs generalizability to persistent dyspnea with other etiologies and its potential for preventing chronification.

FundingMarie Sklodowska-Curie Individual Fellowship (H2020-MSCA-IF-2019 894111/ RESPVR), Bertarelli Foundation

labels: respiratory medicine


sentences:
Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer. Hyperthermia versus Normothermia. A randomized controlled trial. BackgroundThe treatment of ovarian carcinomatosis with cytoreductive surgery and HIPEC is still controversial. The effect and pharmacokinetics of the chemotherapeutics used (specially taxanes) are under consideration at present.

MethodsA phase II, simple blind and randomized controlled trial (NTC02739698) was performed. Thirty-two patients with primary or recurrent ovarian carcinomatosis undergoing cytoreductive surgery (CRS) and intraoperative intraperitoneal chemotherapy with paclitaxel (PTX) were included; 16 in hyperthermic and 16 in normothermic conditions. Tissue, serum and plasma samples were taken in every patient before and after intraperitoneal chemotherapy to measure the concentration of PTX. To analyze the inmunohistochemical profile of p53, p27, p21, ki67, PCNA, caspasa-3 and the pathological response a scale of intensity and percentage of expression and a grouped Miller and Payne system were used, respectively. Perioperative characteristics and morbi-mortality were also analyzed.

ResultsMain characteristics of patients, surgical morbidity, haematoxicity and nephrotoxicity were similar in both groups. The concentration of paclitaxel in the tissue was higher than that observed in plasma and serum, although no statistically significant differences were found between the two groups. No statistically significant association regarding pathological response and apoptosis (caspasa-3) between both groups was proved. Intraperitoneal PTX reduced the expression of p53, p27, p21, ki67 and PCNA more in hyperthermia group, but not significantly.

ConclusionThe use of intraperitoneal PTX has proven an adequate pharmacokinetics with reduction of cell cycle and proliferation markers globally without finding differences between its administration in hyperthermia versus normothermia conditions.

labels: surgery


sentences: Identifying opportunities for improving the organ supply through race-stratified data Organ procurement in the US has received attention from government officials and policymakers the last two years, culminating in CMS releasing an updated Final Rule related to organ donation this year. This regulatory change revises how organ procurement organizations (OPOs), the federal contractors tasked with managing deceased donation, are evaluated and certified/de-certified. We used 2019 data and the CMS methodology to calculate race-stratified donation data among racial/ethnic minorities across the 57 OPOs. We found that the variability in donation rates across the 57 OPOs are greater among minority populations than non-Hispanic white potential donors. Among Tier 3 OPOs, there are: a) some with low donation rates across all racial/ethnic groups; b) some with low donation rates among only certain groups, and c) some where donation rates are lowest among non-Hispanic white patients. Among low-performing OPOs, these race/ethnicity-stratified data show that under-performance in certain areas is not due to the population demographics, and identifies areas for targeted interventions to increase donation and avoid decertification

labels: transplantation


sentences: Longitudinal Evaluation of Magnetic Resonance Spectroscopy Metabolites as Biomarkers in Huntingtons Disease Magnetic resonance spectroscopy (MRS) is a non-invasive method of exploring cerebral metabolism. In Huntingtons disease, altered MRS-determined concentrations of several metabolites have been described; however, findings are often discrepant and longitudinal studies of metabolite trajectory are lacking. MRS metabolites may represent a valuable source of biomarkers, thus their relationship with established biofluid and structural imaging markers of disease progression require further exploration to assess prognostic value and elucidate biochemical pathways associated with neurodegeneration. In a prospective single-site controlled cohort study with standardised collection of CSF, blood, phenotypic and imaging data, we used MRS to evaluate metabolic profiles in the putamen of 56 participants at baseline (15 healthy controls, 15 premanifest and 26 manifest gene expansion carriers) and at 2-year follow-up. Intergroup differences and associations with established measures were assessed cross-sectionally using generalized linear models and partial correlation, controlling for age and CAG repeat length. We report no significant groupwise differences in metabolite concentration but found several metabolites to be associated with measures of disease progression; however, only two relationships were replicated across both time points, with total Creatine (creatine + phosphocreatine) and myo-inositol displaying significant associations with reduced caudate volume. Although relationships were observed between MRS metabolites and biofluid measures, these were not consistent across time points. To further assess prognostic value of the metabolites, we examined whether baseline MRS values, or rate of change, predicted subsequent change in established measures of disease progression. Several associations were found but were inconsistent across known indicators of disease progression. Finally, longitudinal mixed effects models, controlling for age, revealed no significant change in metabolite concentration over time in gene expansion carriers. Altogether, our findings show some interesting cross-sectional associations between select metabolites, namely total creatine and myo-inositol, and markers of disease progression, potentially highlighting the proposed roles of neuroinflammation and metabolic dysfunction in disease pathogenesis. However, the absence of group differences, inconsistency between baseline and follow-up, and lack of clear longitudinal change over two years suggests that MRS metabolites have limited potential as biomarkers in Huntingtons disease.

labels: neurology


sentences:
Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North Carolina BackgroundThe duration of protection afforded by Covid-19 vaccines in the United States is unclear. Whether the recent increase of breakthrough infections was caused by waning immunity to the primary vaccination or by emergence of new variants that are more highly transmissible is also unknown.

MethodsWe extracted data on vaccination histories and clinical outcomes (Covid-19, hospitalization, death) for the period from December 13, 2020 through September 8, 2021 by linking data from the North Carolina COVID-19 Surveillance System and COVID-19 Vaccine Management System covering [~]10.6 million residents statewide. We used the Kaplan-Meier method to estimate the effectiveness of the BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and Ad26.COV2.S (Janssen) vaccines in reducing the incidence of Covid-19 over successive post-vaccination time periods, producing separate estimates for individuals vaccinated during different calendar periods. In addition, we used Cox regression with time-dependent vaccination status and time-varying hazard ratios to estimate the effectiveness of the three vaccines in reducing the hazard rates or current risks of Covid-19, hospitalization, and death, as a function of time elapsed since the first dose.

ResultsFor the Pfizer two-dose regimen, vaccine effectiveness in reducing the current risk of Covid-19 ramps to a peak level of 94.9% (95% confidence interval [CI], 94.5 to 95.2) at 2 months (post the first dose) and drops to 70.1% (95% CI, 68.9 to 71.2) after 7 months; effectiveness in reducing the current risk of hospitalization ramps to a peak level of 96.4% (95% CI, 94.7 to 97.5) at 2 months and remains at 87.7% (95% CI, 84.3 to 90.4) at 7 months; effectiveness in reducing the current risk of death ramps to 95.9% (95% CI, 92.9 to 97.6) at 2 months and is maintained at 88.4% (95% CI, 83.0 to 92.1) at 7 months. For the Moderna two-dose regimen, vaccine effectiveness in reducing the current risk of Covid-19 ramps to a peak level of 96.0% (95% CI, 95.6 to 96.4) at 2 months and drops to 81.9% (95% CI, 81.0 to 82.7) after 7 months; effectiveness in reducing the current risk of hospitalization ramps to a peak level of 97.5% (95% CI, 96.3 to 98.3) at 2 months and remains at 92.3% (95% CI, 89.7 to 94.3) at 7 months; effectiveness in reducing the current risk of death ramps to 96.0% (95% CI, 91.9 to 98.0) at 3 months and remains at 93.7% (95% CI, 90.2 to 95.9) at 7 months. For the Janssen one-dose regimen, effectiveness in reducing the current risk of Covid-19 ramps to a peak level of 79.0% (95% CI, 77.1 to 80.7) at 1 month and drops to 64.3% (95% CI, 62.3 to 66.1) after 5 months; effectiveness in reducing the current risk of hospitalization ramps to a peak level of 89.8% (95% CI, 78.8 to 95.1) at 2 months and stays above 80% through 5 months; effectiveness in reducing the current risk of death ramps to 89.4% (95% CI, 52.3 to 97.6) at 3 months and stays above 80% through 5 months. For all three vaccines, the ramping and waning patterns are similar for individuals who were vaccinated at different dates, and across various demographic subgroups (age, sex, race/ethnicity, geographic region, county-level vaccination rate).

ConclusionsThe two mRNA vaccines are remarkably effective and durable in reducing the risks of hospitalization and death. The Janssen vaccine also offers a high level of protection against hospitalization and death. The Moderna vaccine is significantly more durable than the Pfizer vaccine in reducing the risk of Covid-19. Waning vaccine effectiveness is caused primarily by declining immunity rather than emergence of new variants. It would be worthwhile to investigate the effectiveness of the Janssen vaccine as a two-dose regimen, with the second dose given approximately 1-2 months after the first dose.

labels: infectious diseases


sentences: Rapid surveillance platforms for key SARS-CoV-2 mutations in Denmark Multiple mutations in SARS-CoV-2 variants of concern (VOCs) may increase, transmission, disease severity, immune evasion and facilitate zoonotic or anthoprozoonotic infections. Four such mutations, {Delta}H69/V70, L452R, E484K and N501Y, occur in the SARS-CoV-2 spike glycoprotein in combinations that allow detection of the most important VOCs. Here we present two flexible RT-qPCR platforms for small-and large-scale screening to detect these mutations, and schemes for adapting the platforms for future mutations. The large-scale RT-qPCR platform, was validated by pair-wise matching of RT-qPCR results with WGS consensus genomes, showing high specificity and sensitivity. Detection of mutations using this platform served as an important interventive measure for the Danish public health system to delay the emergence of VOCs and to gain time for vaccine administration. Both platforms are valuable tools for WGS-lean laboratories, as well for complementing WGS to support rapid control of local transmission chains worldwide.


sentences: Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off Serological surveillance studies sometimes use presence of anti-nucleocapsid antibody as a marker of natural SARS-CoV-2 infection. We explore seroconversion rates and antibody levels following Alpha and Delta variant infections, and vaccine breakthrough infections. We find lower seroconversion rates particularly following Alpha-variant vaccine breakthrough infections. We re-evaluate assay performance with a mix of past waned infections and recent breakthrough infections, that is relevant to current serological surveillance.


sentences:
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada BackgroundThe Canadian COVID-19 immunization strategy deferred second doses and allowed mixed schedules. We compared two-dose vaccine effectiveness (VE) by vaccine type (mRNA and/or ChAdOx1), interval between doses, and time since second dose in two of Canadas larger provinces.

MethodsTwo-dose VE against infections and hospitalizations due to SARS-CoV-2, including variants of concern, was assessed between May 30 and October 2, 2021 using test-negative designs separately conducted among community-dwelling adults [≥]18-years-old in British Columbia (BC) and Quebec, Canada.

FindingsIn both provinces, two doses of homologous or heterologous SARS-CoV-2 vaccines were associated with [~]95% reduction in the risk of hospitalization. VE exceeded 90% against SARS-CoV-2 infection when at least one dose was an mRNA vaccine, but was lower at [~]70% when both doses were ChAdOx1. Estimates were similar by age group (including adults [≥]70-years-old) and for Delta-variant outcomes. VE was significantly higher against both infection and hospitalization with longer 7-8-week vs. manufacturer-specified 3-4-week interval between doses. Two-dose mRNA VE was maintained against hospitalization for the 5-7-month monitoring period and while showing some decline against infection, remained [≥]80%.

InterpretationTwo doses of mRNA and/or ChAdOx1 vaccines gave excellent protection against hospitalization, with no sign of decline by 5-7 months post-vaccination. A 7-8-week interval between doses improved VE and may be optimal in most circumstances. Findings indicate prolonged two-dose protection and support the use of mixed schedules and longer intervals between doses, with global health, equity and access implications in the context of recent third-dose proposals.


sentences: Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 variant of concern Gamma and lineage P.2 in Brazil The COVID-19 epidemic in Brazil experienced two major country-wide lineage replacements, the first driven by the lineage P.2, formerly classified as variant of interest (VOI) Zeta in late 2020 and the second by the variant of concern (VOC) Gamma in early 2021. To better understand how these SARS-CoV-2 lineage turnovers occurred in Brazil, we analyzed 11,724 high-quality SARS-CoV-2 whole genomes of samples collected in different country regions between September 2020 and April 2021. Our findings indicate that the spatial dispersion of both variants in Brazil was driven by short and long-distance viral transmission. The lineage P.2 harboring Spike mutation E484K probably emerged around late July 2020 in the Rio de Janeiro (RJ) state, which contributed with most ([~]50%) inter-state viral disseminations, and only became locally established in most Brazilian states by October 2020. The VOC Gamma probably arose in November 2020 in the Amazonas (AM) state, which was responsible for 60-70% of the inter-state viral dissemination, and the earliest timing of community transmission of this VOC in many Brazilian states was already traced to December 2020. We estimate that variant Gamma was 1.56-3.06 more transmissible than variant P.2 co-circulating in RJ and that the median effective reproductive number (Re) of Gamma in RJ and SP states (Re = 1.59-1.91) was lower than in AM (Re = 3.55). In summary, although the epicenter of the lineage P.2 dissemination in Brazil was the heavily interconnected Southeastern region, it displayed a slower rate of spatial spread than the VOC Gamma originated in the more isolated Northern Brazilian region. Our findings also support that the VOC Gamma was more transmissible than lineage P.2, although the viral Re of the VOC varied according to the geographic context.


sentences: SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, Spikevax) or vector-based (Janssen, Vaxzevria) vaccines, using samples from a Dutch nationwide cohort. mRNA vaccines induced faster inclines and higher S1 antibodies compared to vector-based vaccines in adults 18-64 years old (n=2,412). For all vaccines, one dose resulted in boosting of S1 antibodies in adults with a history of SARS-CoV-2 infection. For Comirnaty, two to four months following the second dose (n=196), S1 antibodies in adults aged 18-64 years old (436 BAU/mL, interquartile range: 328-891) were less variable and median concentrations higher compared to those in persons [≥]80 years old (366, 177-743), but differences were not statistically significant (p>0.100). Nearly all participants seroconverted following COVID-19 vaccination, including the aging population. These data confirm results from controlled vaccine trials in a general population, including vulnerable groups.


sentences: Increased interhemispheric asymmetry of cerebral blood flow in comatose adult patients on extracorporeal membrane oxygenation Extracorporeal membrane oxygenation (ECMO) is a mechanical circulatory support method that is associated with a high burden of neurologic injury, but neurologic examination and imaging of this population presents prohibitive medical and logistical challenges. Diffuse correlation spectroscopy (DCS) can measure relative cerebral blood flow (rBF) non-invasively at the bedside. In this study we observed interhemispheric differences in rBF in response to mean arterial pressure (MAP) changes in adult ECMO recipients. Thirteen patients were recruited (ages 21-78, 7 with cardiac arrest, 4 with acute heart failure, 2 with acute respiratory distress syndrome). They were dichotomized via Glasgow Coma Scale Motor score (GCS-M) into comatose (GCS-M [≤] 4; n=4) and non-comatose (GCS-M > 4; n=9) groups. Comatose patients had more interhemispheric rBF asymmetry (ASYMrBF) vs. non-comatose patients over a range of MAP values (29% [IQR 23-34%] vs. 11% [IQR 8-13%], p=0.009). ASYMrBF in comatose patients resolved near a MAP range of 70-80 mm Hg, while rBF remained symmetric through a wider MAP range in non-comatose patients. Associations between post-oxygenator pCO2 or pH vs. ASYMrBF individually did not meet significance, though the linear model slopes were different between comatose and non-comatose subgroups. Here we have demonstrated asymmetric cerebral autoregulation in comatose ECMO patients.

labels: intensive care and critical care medicine


sentences:
Factors Associated with Medicine Timing Effects: A Meta-analysis ImportanceClinical evidence suggests that the time of day of treatment can affect outcomes in many different diseases, but this information is dispersed, imprecise, and heterogeneous. Consequently, practice guidelines and clinical care recommendations seldom specify intervention time.

ObjectiveTo understand the sources of variability and summarize clinical findings on the time of day effects of medicine.

Data SourcesA systematic search of Pubmed, Google Scholar, and ClinicalTrials.gov for "chronotherapy" OR "time of administration".

Study SelectionAny clinical study since 2000, randomized or observational, that compared the effects of treatment at different times of day. We included pharmacologic or surgical interventions having at least one continuous outcome.

Data Extraction and SynthesisFor selected studies, we extracted the mean and variance of each time-of-day treatment group. From these, we computed the standardized mean difference (SMD) as the measure of timing effect. Where a study reported multiple outcomes, we selected a single outcome based on a defined order of priority.

Main Outcomes and MeasuresWe estimated overall pooled effect size and heterogeneity by a random effects model, followed by outlier detection and subgroup analyses to evaluate how study factors, including drug, design, outcome, and source, associate with timing effect.

Results78 studies met the inclusion criteria, comprising 48 distinct interventions over many therapeutic areas. We found an overall effect of time on clinical outcomes but with substantial heterogeneity between studies. Predicted effects range from none to large depending on the study context. Study size, registration status, and source are associated with the magnitude of effect. Larger trials and those that were pre-registered have markedly smaller effects, suggesting that the published record overstates the effects of the timing of medicine on clinical outcomes. In particular, the notion that antihypertensives are more effective if taken at bedtime draws disproportionately from one source in the field, which consistently detects larger effects than the community average. Lastly, among the most highly studied drug timing relationships, aspirins anti-clotting effect stands out, consistently favoring evening over morning dosing.

Conclusions and RelevanceWhile accounts of drug timing effects have focused on yes/no, appreciating the range of probable effects may help clarify where  circadian medicine meets the threshold for clinical benefit.

labels: cardiovascular medicine


sentences:
Cholera outbreaks in sub-Saharan Africa during 2010-2019: A Descriptive Analysis BackgroundCholera remains a public health threat, but is inequitably distributed, especially affecting areas without universal access to safe water and sanitation, including much of sub-Saharan Africa. Lack of standardized reporting and inconsistent outbreak definitions limit our understanding of cholera outbreak epidemiology.

MethodsWe curated a database of cholera incidence and mortality from sub-Saharan Africa from 2010 to 2020 and developed methods to reconstruct epidemic curves. We then described the distribution of key outbreak metrics, including outbreak size and duration.

ResultsWe identified 999 suspected cholera outbreaks in 744 unique regions across 25 sub-Saharan Africa countries, and outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 through January 2020. Among the 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1,000 people (IQR, 0.3-2.4 per 1,000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Rural outbreaks had more than twice the case fatality risk than urban ones (median of 1.8% versus 0.8%). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks.

ConclusionsDespite reporting gaps and the limitations of analyzing outbreaks by administrative units, this work provides a baseline from which to monitor progress towards cholera control and essential statistics to inform outbreak management and emergency response in sub-Saharan Africa.

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe used PubMed to search for relevant studies published between 2010 and 2019, using the term "Cholera AND (Outbreak OR epidemic) AND (Africa OR Algeria OR Angola OR Benin OR Botswana OR Burkina Faso OR Burundi OR Cabo Verde OR Cameroon OR Central African Republic OR Chad OR Comoros OR Congo Democratic Republic of the OR Congo, Republic of the OR Cote dIvoire OR Djibouti OR Egypt OR Equatorial Guinea OR Eritrea OR Eswatini OR Ethiopia OR Gabon OR Gambia OR Ghana OR Guinea OR Guinea-Bissau OR Kenya OR Lesotho OR Liberia OR Libya OR Madagascar OR Malawi OR Mali OR Mauritania OR Mauritius OR Morocco OR Mozambique OR Namibia OR Niger OR Nigeria OR Rwanda OR Sao Tome and Principe OR Senegal OR Seychelles OR Sierra Leone OR Somalia OR South Africa OR South Sudan OR Sudan OR Tanzania OR Togo OR Tunisia OR Uganda OR Zambia OR Zimbabwe)". Of 544 results, 137 were either not about cholera outbreaks or were about cholera outbreaks in a particular country or context and 407 were not about cholera outbreaks. The remaining three were a review of cholera outbreaks in Africa by Martin et al, who focused on general epidemiology and biology of cholera outbreaks before 2011; a review of epidemiology of cholera by Jacqueline et al, who explored the duration, case fatality rate, genomics, risk factors and surveillance of outbreaks across Africa before 2017; and a study of recurrent outbreaks in Africa by Abraham et al, who examined the historical trends, risk factors, burden, severity and control strategies of outbreaks by geographic regions based on available reports from January, 1970 through August, 2017. In addition, a summary table developed by Medecins Sans Frontieres (MSF) for cholera outbreak management and response in the field provided major outbreak characteristics (e.g., attack rate, duration, time to outbreak peak) in rural settings, urban settings and slums, and closed situations (e.g., refugee camps) based on a review of cholera epidemics between 1990 and 1997.

Added value of this studyPrevious reviews based on available outbreak reports reflect restricted summaries of outbreak characteristics. To present a comprehensive and up-to-date summary for outbreaks in sub-Saharan Africa, we examined key outbreak features by applying a systematic outbreak definition to time series from a large cholera incidence database. To our knowledge, this is the largest centralized source of global cholera incidence and mortality data. We identified 999 suspected cholera outbreaks in 744 sub-national regions across 25 countries in sub-Saharan Africa, where 2% or 1.8 billion person-months of the total population were living in regions with ongoing outbreaks in the period from 2010 through 2019. In addition, our results suggest that population density may not be universally associated with more severe outbreak outcomes. Compared to historical summaries from MSF, our estimates of attack rates and CFRs are much lower in both rural and urban settings, while the estimate of proportion of cases reported during the peak week is slightly higher, leading to only one-third to one-fourth of the previous estimation of peak bed capacity.

Implications of all the available evidenceCholera remains a public health threat in sub-Saharan Africa. This summary of the characteristics and transmission dynamics of outbreaks occurring in sub-Saharan Africa in the period from 2010 through 2019 increases our understanding of cholera outbreak epidemiology and serves as a practical source for future outbreak management and response. As several sub-Saharan African countries have started to developed country plans to reduce cholera incidence in the coming years, our study emphasizes the importance of improving cholera monitoring and surveillance (e.g., laboratory confirmation and finer geographic scale of reporting) in order to identify finer-scale outbreaks, estimate the true burden of cholera and target interventions with limited resources.

labels: epidemiology


sentences: Epidemiological, virological and serological investigation into a SARS-CoV-2 outbreak (Alpha variant) in a primary school in Geneva, Switzerland: a prospective longitudinal study We report a prospective epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak in a primary school, as part of a longitudinal, prospective, primary school-based surveillance study. It involved repeated testing of pupils and teachers and household members of participants who tested positive, with rapid antigen tests and/or RT-PCR (Day 0-2 and Day 5-7), serologies on dried capillary blood samples (Day 0-2 and Day 30), contact tracing interviews and SARS-CoV-2 whole genome sequencing. This SARS-CoV-2 outbreak caused by the Alpha variant involved 20 children aged 4 to 6 years from 4 classes, 2 teachers and a total of 4 household members. Infection attack rates were between 11.8 and 62.0% among pupils from the 4 classes, 22.2% among teachers and 0% among non-teaching staff. Secondary attack rate among household members was 15.4%. Symptoms were reported by 63% of infected children, 100% of teachers and 50% of household members. All analysed sequences but one showed 100% identity. Serological tests detected 8 seroconversions unidentified by SARS-CoV-2 virological tests. This study confirmed child-to-child and child-to-adult transmission of the infection. Effective measures to limit transmission in schools have the potential to reduce the overall community circulation.


sentences: Molecular epidemiological characteristics of Mycobacterium abscessus complex in non-cystic fibrosis patients in Japan and Taiwan Mycobacterium abscessus complex (MABC) is an emerging non-tuberculous mycobacterium (NTM). Specific MABC clones are reportedly spreading globally in cystic fibrosis (CF) patients, however, associated genomic epidemiology studies are lacking in East Asia. Analysis of whole-genome sequencing data for MABC isolates from 220 pre-treatment, non-CF patients in Japan and Taiwan revealed that 112/220, 105/220, and 3/220 were M. abscessus subsp. abscessus (ABS), M. abscessus subsp. massiliense (MAS), and M. abscessus subsp. bolletii (BOL), respectively. No significant differences in subspecies composition were noted based on location. Moreover, >50% of ABS and >70% of MAS were related to four predominant clones in the region. Known mutations conferring acquired macrolide resistance were rare (1.4%) and not enriched in the predominant clones. Conversely, the macrolide-susceptible erm(41) T28C mutation was significantly enriched in one predominant ABS clone. The most predominant ABS clone was genetically related to the dominant circulating clone (DCC). Hence, we have clarified the relationship between the predominant clones in Japan and Taiwan, and those reported in the international CF patient community. Our results provide insights regarding the genetic characteristics of globally dominant and area-specific strains isolated from patients with or without CF, as well as differences between globally spread and regionally-specific strains.


sentences:
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations BackgroundVaccines have greatly reduced the impact of COVID-19, but vaccine protection against milder disease and infection have waned significantly, especially for the Delta variant (B.1.617.2). A third booster dose of two-dose vaccines could restore protection but the benefit of boosting immunity in younger healthy individuals and the resultant effects on transmission have not been quantified.

MethodsWe develop relationships between neutralizing antibody titers and vaccine protection against both infection and transmission. We combine these relationships with data on waning and boosting of neutralizing antibody titers to examine the impact of third doses of Pfizer-BioNtech and Moderna vaccines on infection and transmission and the impact on the pathogen effective reproductive number Rt.

FindingsWaning reduced protection of the Pfizer-BioNtech vaccine against all infections from 80.0% (95% CI: 77% to 83%) to 60.4% (95% CI: 53% to 67%), and for the Moderna vaccine from 83.8 (95% CI: 80 to 87%) to 65.9% (95% CI: 61-71%). A third dose increased neutralizing antibody titers 25.9-fold relative to waned levels for the Pfizer-BioNtech vaccine and 13-fold relative to waned levels for the Moderna vaccine. This increased protection against infection to 87.2% (95% CI: 83% to 91%) and 86.3% (95% CI: 82% to 90%) for Pfizer and Moderna, respectively. Increased protection against infection and transmission from third doses reduced Rt by 28% to 74% depending on vaccine coverage and previous infection and reduced Rt below 1 when vaccination coverage was high or contact rates were well below pre-pandemic levels.

InterpretationA third vaccine dose could substantially reduce transmission of SARS-CoV-2 and prevent future surges, with the impact increasing with vaccine coverage and contact rates among individuals. Reducing transmission would reduce infection in both unvaccinated individuals and breakthrough infections in vaccinated individuals.

FundingCalifornia Department of Health, National Science Foundation


sentences:
Association between social media use and self-reported symptoms of depression in US adults ImportanceSome studies suggest that social media use is associated with risk for depression, particularly among children and young adults.

ObjectiveTo characterize the association between self-reported use of individual social media platforms, and worsening of depressive symptoms, among adults.

DesignWe included data from 13 waves of a non-probability internet survey conducted between May 2020 and May 2021 among individuals age 18 and older in the United States. We applied logistic regression with 5 or more point increase in PHQ-9 as outcome, and sociodemographic features, baseline PHQ-9, and use of each social media platform as independent variables, without reweighting.

ParticipantsSurvey respondents 18 and older.

Main Outcome and MeasurePHQ-9 worsening by 5 points or more.

ResultsA total of 5395/8045 (67.1%) individuals with a PHQ-9<5 on initial survey completed a second PHQ-9. These respondents had mean age 55.82 years (SD 15.17); 3546 (65.7%) reported female gender, the remainder male; 329 (6.1%) were Asian, 570 (10.6%) Black, 256 (4.7%) Hispanic, 4118 (76.3%) White, and 122 (2.3%) Native American or Alaska Native, Pacific Islander or Native Hawaiian, or Other. Among them, 482 (8.9%) reported 5 point or greater worsening at second survey. In fully-adjusted models for increase in symptoms, largest odds ratio associated with social media use was observed for Snapchat (aOR 1.53, 95% CI 1.19-1.96), Facebook (aOR 1.42, 1.10-1.81), and TikTok (aOR 1.39, 95% CI 1.03-1.87).

Conclusions and RelevanceAmong survey respondents who did not report depressive symptoms initially, social media use was associated with greater likelihood of subsequent increase in depressive symptoms after adjustment for sociodemographic features and news sources. These data cannot elucidate the nature of this relationship, but suggest the need for further study to understand the impact of social media use.

Trial RegistrationNA


sentences:
Development of health and safety training for Vietnamese American nail salon owners and workers BackgroundNail salon workers are an underserved worker population that faces multiple barriers to accessing occupational health training and services. We developed a series of occupational health training modules, which were culturally tailored to Vietnamese-speaking workers, covering topics on infection control, musculoskeletal disorder prevention, chemical safety, and labor practices. We delivered the training online (due to COVID-19) to a small group of Vietnamese owners and workers in the Philadelphia metro area to obtain feedback on the training content and potential implementation challenges.

MethodsSeven participants (three owners and four workers) were recruited to attend the training. Qualitative feedback was obtained after each training session, followed by a more in-depth interviewer-assisted open-ended questionnaire to gain better understanding of the potential challenges of implementing the recommended changes. The Health Belief Model was used to guide the analysis of the participants responses to identify the perceived benefits and barriers of the training.

ResultsThemes of perceived benefits of the training were bridging the gap of cosmetology school training, offering practical tips to protect their health at work, and inspiring conversations about work dignity and labor practices. Themes of perceived barriers were availability of affordable safer products and lack of resources, desire to please customers, lack of commitment from owners, and ubiquitous low wage that impacts employees job satisfaction and motivation to change, and difficulty in obtaining a work license.

ConclusionsOur study revealed the multitude of social and economic barriers facing immigrant nail salon owners and workers. Potential policies and strategies to overcome some of these structural barriers are discussed for the long-term health protection of nail salon workers.


sentences:
Preliminary outcomes of combined treadmill and overground high-intensity interval training in ambulatory chronic stroke IntroductionLocomotor high-intensity interval training (HIIT) is a promising intervention for stroke rehabilitation that typically involves bursts of fast treadmill walking alternated with recovery periods. However, overground translation of treadmill speed gains has been somewhat limited, some important outcomes have not been tested and baseline response predictors are poorly understood. This pilot study aimed to guide future research by assessing preliminary outcomes of combined overground and treadmill HIIT.

MethodsTen participants >6 months post stroke completed a multi-domain assessment battery before and after a 4-week no-intervention control phase, then again after a 4-week treatment phase involving 12 sessions of overground and treadmill HIIT. The primary analyses assessed relative changes in overground and treadmill walking speeds after HIIT, evaluated responsiveness of different outcome measures and estimated effects of baseline gait speed on treatment response.

ResultsOverground and treadmill gait function both improved during the treatment phase relative to the control phase, with overground speed changes averaging 61% of treadmill speed changes (95% CI: 33-89%). Moderate or larger effect sizes were observed for measures of gait performance, balance, fitness, cognition, fatigue, perceived change and brain volume. Participants with baseline comfortable gait speed <0.4 m/s had less absolute improvement in walking capacity but similar proportional and perceived changes.

DiscussionFuture locomotor HIIT studies should consider including: 1) both overground and treadmill training; 2) measures of cognition, fatigue and brain volume, to complement typical motor & fitness assessment; and 3) baseline gait speed as a covariate.


sentences:
Assessing the impact of race on glomerular filtration rate (GFR) prediction BackgroundThe appropriate use and the implications of using variables that attempt to encode a patients race in clinical predictive algorithms remain unclear. The clinical algorithm for estimating glomerular filtration rate (GFR) adjusts for race, but the observed difference between Black and non-Black participants lacks biologically substantiated evidence. We investigated the impact of using a race variable on GFR prediction by race-stratified error analysis.

MethodsWe implemented three predictive algorithms with varied amount of input information from an electronic health record database to estimate GFR. We compared the prediction error of the estimated GFR with and without the variable race between Black patients and White patients.

ResultsThe prediction error for patients coded as Black was higher than that for patients coded as White across all three algorithms. Removing race from the prediction algorithm did not lower the prediction error for patients coded as Black, neither did it decrease the difference in error between the two groups. The algorithm that included the most information with thousands of variables but excluding race produced the most accurate estimate for both groups and minimized the difference in performance between the two groups.

ConclusionThe prediction error for patients coded as Black was higher compared to those coded as White, regardless of inclusion of race as a variable. Using a large amount of information represented in electronic health record variables achieved a more accurate prediction of GFR and the least difference in prediction error across racial groups.

labels: nephrology


sentences: Phenotypic and genetic factors associated with differential consent to record linkage for prescription history in the Australian Genetics of Depression Study Samples can be prone to ascertainment and attrition biases.The Australian Genetics of Depression Study is a large publicly recruited cohort (n=20,689) established to increase the understanding of depression and antidepressant treatment response. As part of the recruitment, participants donated a saliva sample and were given the option to consent to linkage of prescription records for research purposes. This study investigates differences between participants who donated a saliva sample or agreed to linkage of their records compared to those who did not. We observed that older, male participants with a higher education were more likely to donate a saliva sample. Self-reported bipolar disorder, ADHD, panic disorder, PTSD, substance use disorder and social anxiety disorder were associated with lower odds of donating a saliva sample whereas anorexia was associated with higher odds of donation. Male and younger participants showed higher odds of agreeing to record linkage. Participants with higher neuroticism scores and those with a history of bipolar disorder were also more likely to agree to record linkage whereas participants with a diagnosis of anorexia were less likely to agree. Increased likelihood of consent was also associated with increased genetic susceptibility to anorexia and reduced genetic risk for depression, and schizophrenia whereas there was no significant genetic effect for neuroticism. Overall, our results show moderate differences among these subsamples. Most current epidemiological studies do not adjust, nor search, for attrition biases at the genetic level. The possibility to do so is a strength of samples such as the AGDS. Our results suggest that analyses can be made more robust by identifying attrition biases both on the phenotypic and genetic level, and either contextualising them as a potential limitation or performing sensitivity analyses adjusting for them.

labels: genetic and genomic medicine


sentences: Prediction of recessive inheritance for missense variants in human disease The prediction of pathogenic human missense variants has improved in recent years, but a more granular level of variant characterization is required. Further axes of information need to be incorporated in order to advance the genotype-to-phenotype map. Recent efforts have developed mode of inheritance prediction tools; however, these lack robust validation and their discrimination performance does not support clinical utility, with evidence of them being fundamentally insensitive to recessive acting diseases. Here, we present MOI-Pred, a three-way variant-level mode of inheritance prediction tool aimed at recessive identification for missense variants. MOI-Pred shows strong ability to discriminate missense variants causing autosomal recessive disease (area under the receiver operating characteristic (AUROC)=0.99 and sensitivity=0.85) in an external validation set. Additionally, we introduce an electronic health record (EHR)-based validation approach using real-world clinical data and show that our recessive predictions are enriched for recessive associations with human diseases, demonstrating utility of our method. Mode of inheritance predictions - pathogenic for autosomal recessive (AR) disease, pathogenic for autosomal dominant (AD) disease, or benign - for all possible missense variants in the human genome are available at https://github.com/rondolab/MOI-Pred/.


sentences:
Optimising the balance of acute and intermediate care capacity for the complex discharge pathway: computer modelling study during COVID-19 recovery in England ObjectivesWhile there has been significant research on the pressures facing acute hospitals during the COVID-19 pandemic, there has been less interest in downstream community services which have also been challenged in meeting demand. This study aimed to estimate the theoretical cost-optimal capacity requirement for  step down intermediate care services within a major healthcare system in England, at a time when considerable uncertainty remained regarding vaccination uptake and the easing of societal restrictions.

MethodsDemand for intermediate care was projected using an epidemiological model (for COVID-19 demand) and regressing upon public mobility (for non-COVID-19 demand). These were inputted to a computer simulation model of patient flow from acute discharge readiness to bedded and home-based Discharge to Assess (D2A) intermediate care services. Cost-optimal capacity was defined as that which yielded the lowest total cost of intermediate care provision and corresponding acute discharge delays.

ResultsIncreased intermediate care capacity is likely to bring about lower system-level costs, with the additional D2A investment more than offset by substantial reductions in costly acute discharge delays (leading also to improved patient outcome and experience). Results suggest that completely eliminating acute  bed blocking is unlikely economical (requiring large amounts of downstream capacity), and that health systems should instead target an appropriate tolerance based upon the specific characteristics of the pathway.

ConclusionsComputer modelling can be a valuable asset for determining optimal capacity allocation along the complex care pathway. With results supporting a Business Case for increased downstream capacity, this study demonstrates how modelling can be applied in practice and provides a blueprint for use alongside the freely-available model code.

labels: health systems and quality improvement


sentences:
Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: an open-label, parallel, randomized controlled trial. IntroductionHigh HHV-8 viral load (VL) in Kaposi Sarcoma (KS) has been associated with severe Immune reconstitution inflammatory syndrome (S-IRIS-KS), which can occur after initiating cART, and is linked with high mortality particularly in patients with pulmonary involvement. We investigate if valganciclovir initiated before cART decreases HHV-8 VL and assess if it reduces the incidence of S-IRIS-KS and its attributable mortality.

MethodsOpen-label parallel-group randomized clinical trial in AIDS cART naive patients with disseminated KS (DKS) as defined by at least two of the following: pulmonary, lymph-node or gastrointestinal involvement, lymphedema, or [≥]30 skin lesions. In the experimental group (EG), patients were randomized to valganciclovir 900 mg BID four weeks before cART and continued until week-48; in the control group (CG), cART was initiated on week-0. Non-severe-IRIS-KS was defined as: increase in number of lesions plus [≥]one log10 HIV-VL decrease or [≥]50 cells/mm3 increase or [≥]2-fold rise in baseline CD4+cells. S-IRIS-KS was defined as abrupt clinical worsening of KS lesions and/or fever after ruling out another infection following cART initiation, and at least three of the following: thrombocytopenia, anemia, hyponatremia, or hypoalbuminemia.

Results40 patients were randomized and 37 completed the study. In the ITT analysis, the overall mortality did not differ between groups. In the per-protocol analyses, the difference showed a trend for higher S-IRIS-KS mortality in the CG 3/19 (15.7%), compared to EG 0/18 (p=0.07). The incidence of S-IRIS KS was significantly lower in the EG; two patients, one each had S-IRIS-KS episode (0.038 per 100 patient-days) compared to CG group, four patients developed 12 S-IRIS-KS episodes (0.21 per 100 patient-days); incidence rate of 0.09 (95% CI 0.02-0.5 p=0.006). Mortality in patients with pulmonary KS was significantly lower in EG, 3/4 in CG vs 0/5 in EG. S-IRIS-KS was associated with higher HHV-8-VL; IL6 and CRP; valganciclovir was protective. Of survivors at week 48, 82% achieved >80% remission. No difference was found between groups in the number of non-S-IRIS-KS events.

ConclusionsValganciclovir significantly reduced the episodes of S-IRIS-KS although attributable KS mortality was lower in the EG the difference was not significant (p=0.07). Mortality was significantly lower in EG patients with pulmonary KS.

NIH Clinical Trails ID NCT03296553.

labels: hiv aids


sentences: Limited impact of Delta variants mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population The SARS-CoV-2 pandemic has impacted public health systems all over the world. The Delta variant seems to possess enhanced transmissibility, but no clear evidence suggests it has increased virulence. Our data shows that pre-exposed individuals had similar neutralizing activity against the authentic COVID-19 strain and the Delta and Epsilon variants. After one vaccine dose, the neutralization capacity expands to all tested variants. Healthy vaccinated individuals showed a limited breadth of neutralization. One vaccine dose induced similar neutralizing antibodies against the Delta compared to the authentic strain. However, even after two doses, this capacity only expanded to the Epsilon variant.


sentences:
Assessment of knowledge retention of healthcare staff through telephonic interview after training for rotavirus vaccine introduction in India BackgroundStudies have shown that while training has significant potential in improving the knowledge and skills of healthcare staff, the beneficial effect of training may decline with time. Studies have emphasized the role of assessment in understanding the relevance of the training structure and content and employing course correction as per the need. Besides, there is a lack of literature on the assessment of the level of knowledge retention among the participants. This study aims to conduct an assessment study to determine the level of knowledge retention.

MethodsThe study was conducted among frontline health workers who received training on the rotavirus vaccine introduction. Assessments were conducted at a gap of one month and twelve months after the intervention. Simple percentages were used to compare the level of knowledge retention and McNemars chi-square test to determine P values.

ResultsThis is the first study conducted in India to assess the retention of knowledge 12 months after the new vaccine introduction training of health care professionals. The study comprised 41 participants who demonstrated an increase in the level of knowledge retention at the end of 1-month; however, a decline in the knowledge retention was seen at 12-months. For the issue of missed second dose among children who received the first dose, an increase in knowledge level and retention was observed.

ConclusionThe study results showed that a time-bound decline in knowledge retention occurs. The authors recommend regular monitoring, refresher training to supplement the primary training.


sentences:
Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study BackgroundHundreds of millions of doses of COVID-19 vaccines have been administered globally, but progress in vaccination varies considerably between countries. We aim to provide an overall picture of COVID-19 vaccination campaigns, including policy, coverage, and demand of COVID-19 vaccines.

MethodsWe conducted a descriptive study of vaccination policy and doses administered data obtained from multiple public sources as of 23 October 2021. We used these data to develop coverage indicators and explore associations of vaccine coverage with socioeconomic and healthcare-related factors. We estimated vaccine demand as numbers of doses required to complete vaccination of countries target populations according to their national immunization program policies.

FindingsUse of both mRNA and adenovirus vectored vaccines was the most commonly used COVID-19 vaccines formulary in high-income countries, while adenovirus vectored vaccines were the most widely used vaccines worldwide (176 countries). Almost all countries (98.3%, 173/176) have authorized vaccines for the general public, with 53.4% (94/176) targeting individuals over 12 years and 33.0% (58/176) targeting those [≥]18 years. Forty-one and sixty-seven countries have started additional-dose and booster-dose vaccination programs, respectively. Globally, there have been 116.5 doses administered per 100 target population, although with marked inter-region and inter-country heterogeneity. Completed vaccination series coverage ranged from 0% to more than 95.0% of country target populations, and numbers of doses administered ranged from 0 to 239.6 per 100 target population. Doses administered per 100 total population correlated with healthcare access and quality index (R2 = 0.58), socio-demographic index (R2 = 0.56), and GDP per capita (R2 = 0.65). At least 5.54 billion doses will be required to complete interim vaccination programs - 4.65 billion for primary immunization and 0.89 billion for additional/booster programs. Globally, 0.84 and 0.96 dose per individual in the target population are needed for primary immunization and additional/booster programs, respectively.

InterpretationThere is wide country-level disparity and inequity in COVID-19 vaccines rollout, suggesting large gaps in immunity, especially in low-income countries.

FundingKey Program of the National Natural Science Foundation of China, the US National Institutes of Health.

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched PubMed for articles in any language published up to October 21, 2021, using the following search terms: ("COVID-19" OR "SARS-CoV-2") AND ("vaccination" OR "vaccine") AND ("inequalit*" OR "inequity" OR "disparit*" OR "heterogeneity"). We also searched for dashboards associated with vaccine rollout from public websites. We identified several studies on tracking global inequalities of vaccine access, one of which constructed a COVID-19 vaccine dashboard (Our World in Data), and another that explored disparities in COVID-19 vaccination among different-income countries. However, we found no studies that depict global COVID-19 vaccination policies country-by-country and estimate demand for vaccine necessary to completely vaccinate countries designated target populations.

Added value of this studyTo our knowledge, our study provides the most recent picture of COVID-19 vaccination campaigns, focusing on global vaccination policy and target-population demand. We found a diverse portfolio of vaccines in five technical platforms being administered globally, with 173 countries having authorized administration of vaccines to the general public in various age groups. We observed inter-region and inter-country heterogeneity in one-or-more-dose and full-dose coverage; countries with higher socio-demographic or health resource-related levels had higher coverage. We estimated dose-level demand for completing primary immunization programs and additional/booster dose programs separately.

Implications of all the available evidenceWorldwide disparity and inequity of vaccine rollout implies that susceptibility among unvaccinated populations in some countries may impede or reverse pandemic control, especially in face of the emergence of variants and the dilemma of waning antibodies. Our findings suggest that global-level responses to the pandemic - financially, politically, and technically - are needed to overcome complex challenges that lie ahead.


sentences: Performance of Valved Respirators to Reduce Respiratory Particles Generated by Speaking Wearing of face coverings serves two purposes: reducing the concentration of ambient particles inhaled and reducing the emission of respiratory particles generated by the wearer. The efficiency of different face coverings depends on the material, design, and fit. Face coverings such as N95 respirators, when worn properly, are highly efficient at filtering ambient particles during inhalation. Some N95 respirators, as well as other face covering types, include a one-way valve to allow easier exhalation while still maintaining high filtration efficiency towards ambient particles. The extent to which these valves decrease filtration of emitted respiratory particles is, however, not well established. Here, we show that different valved N95s exhibit highly variable filtration efficiencies for exhaled respiratory particles. As such, valved N95s do not provide reliable source control of respired particles and their use should be discouraged in situations where such source control is needed.

labels: occupational and environmental health


sentences: Relationship among work-treatment balance, job stress, and work engagement in Japan: A cross-sectional study There is a drive to support workers undergoing medical treatment who wish to continue working in Japan, known as the work-treatment balance. It is hoped that this support for the work-treatment balance could boost their mental health. This study examines the relationship among the work-treatment balance, job stress, and work engagement. This study was conducted in December 2020 in Japan, with 27,036 participants. We divided the participants into three groups by the receipt state of support for the work-treatment balance: control group (no need the support), unsupported group, and supported group. The scores of the parameters of the job content questionnaire and the Utrecht Work Engagement Scale (UWES-3) were compared among groups using a multilevel regression with age-sex or multivariate-adjusted models. In the two models, the job control score of the unsupported group was significantly lower than that of the control group. The two social support scores of the supported group were significantly higher than those of the control group. The scores of the UWES-3 of the unsupported group were significantly lower than those of the control group. The support of work-treatment balance for workers could have a positive impact on their mental health.


sentences:
Race/ethnicity in relation to incident primary open-angle glaucoma characterized by autonomously determined visual field loss patterns PurposeWe used an autonomous algorithm to classify incident visual field (VF) loss patterns in primary open-angle glaucoma (POAG). Subsequently, we compared racial differences in the risk of these regional VF loss patterns.

Design/ParticipantsParticipants (n=209,036) from the Nurses Health Study (NHS) (follow-up: 1980-2018); NHS2 (1989-2019); and Health Professionals Follow-up Study (HPFS; 1986-2018), aged [≥]40 years and free of glaucoma.

MethodsDemographics, medical and lifestyle information was assessed on biennial questionnaires. Incident POAG cases (n=1946) with reproducible Humphrey VF loss were confirmed with medical records. The total deviation information of the earliest reliable VF for each eye with POAG (n=2564) was extracted, and a statistical learning method was used to identified optimal solutions for regional vision loss patterns. Each POAG eye was assigned the VF pattern ("archetype") based on the highest weighting coefficient.

Multivariable-adjusted hazard ratios (HRs) for POAG of various archetypes and 95% confidence intervals (CIs) were estimated using per-eye Cox proportional hazards models. Covariates included cohort, age, glaucoma family history, socioeconomic status, lifestyle parameters, number of eye exams during follow-up, and medical conditions. False discovery rate (FDR) was used for multiple comparisons.

Main outcome measuresPOAG based on VF patterns.

ResultsMean age was 58 years; 1.3% were Black, 1.2% were Asian, 1.1% were Hispanic-White and 96.4% were non-Hispanic White. We identified 14 archetypes: 1 representing no VF loss, 9 of early loss and 4 of advanced loss patterns. Compared to non-Hispanic Whites, Blacks were at significantly higher risk of POAG with early VF loss archetypes collectively (Blacks: HR=1.96, 95% CI=1.46, 2.63) and at even higher risk for POAG with advanced loss archetypes collectively (Blacks: HR=6.07, 95% CI=3.61, 10.21; p=0.0002 for the two estimates being different); no differences were observed for Asians or Hispanic Whites. For individual VF archetypes, Hispanic-Whites had FDR-significant higher risks of POAG of archetypes showing early paracentral defects and advanced superior loss while Blacks had FDR-significant higher risks of all advanced loss archetypes and 3 early loss patterns, including early paracentral defects.

ConclusionAmong health professionals, compared to non-Hispanic-Whites, Blacks and Hispanic-Whites had higher risks of incident POAG with central and advanced VF loss.

labels: ophthalmology


sentences:
The contributions of cartilage endplate composition and vertebral bone marrow fat to intervertebral disc degeneration in patients with chronic low back pain PurposeThe composition of the subchondral bone marrow and cartilage endplate (CEP) could affect intervertebral disc health by influencing vertebral perfusion and nutrient diffusion. However, the relative contributions of these factors to disc degeneration in patients with chronic low back pain (cLBP) have not been quantified. The goal of this study was to use compositional biomarkers derived from quantitative MRI to establish how CEP composition (surrogate for permeability) and vertebral bone marrow fat fraction (BMFF, surrogate for perfusion) relate to disc degeneration.

MethodsMRI data from 60 patients with cLBP were included in this prospective observational study (28 female, 32 male; age = 40.0 {+/-} 11.9 years, 19-65 [mean {+/-} SD, min-max]). Ultra-short echo-time MRI was used to calculate CEP T2* relaxation times (reflecting biochemical composition), water-fat MRI was used to calculate vertebral BMFF, and T1{rho} MRI was used to calculate T1{rho} relaxation times in the nucleus pulposus (NP T1{rho}, reflecting proteoglycan content and degenerative grade). Univariate linear regression was used to assess the independent effects of CEP T2* and vertebral BMFF on NP T1{rho}. Mixed effects multivariable linear regression accounting for age, sex, and BMI was used to assess the combined relationship between variables.

ResultsCEP T2* and vertebral BMFF were independently associated with NP T1{rho} (p = 0.003 and 0.0001, respectively). After adjusting for age, sex, and BMI, NP T1{rho} remained significantly associated with CEP T2* (p = 0.0001) but not vertebral BMFF (p = 0.43).

ConclusionPoor CEP composition may play a significant role in disc degeneration severity and can affect disc health both with and without deficits in vertebral perfusion.

labels: orthopedics


sentences:
Dementia and hearing-aid use: a two-way street ObjectivesHearing-aid use may reduce risk of dementia, but cognitive impairment makes hearing-aid use more challenging. These two causal pathways may both manifest as an association between reduced hearing-aid use and incident dementia. This study examined the effects of each pathway separately, through a unique combination of longitudinal data regarding hearing, general health, dementia diagnoses and continuity of HA use.

MethodsLongitudinal health records data from 380,794 Veterans who obtained hearing aids from the US Veterans Affairs healthcare system were analysed. Analysis 1 (n=72,180) used logistic regression to model the likelihood of a dementia diagnosis at 3 year 6 months (3y6m) to 5 years post hearing-aid fitting for patients previously free of dementia and mild cognitive impairment (MCI). Analysis 2 (n=350,918) modelled the likelihood of being a persistent hearing aid user at 3y2m after fitting, contrasting sub-groups with differing levels of cognitive function at the time of fitting. Models controlled for relevant predictors available in the dataset.

ResultsIn analysis 1, the adjusted OR for incident dementia was 0.73 (ci 0.66-0.81) for persistent (vs. non persistent) hearing-aid users. In analysis 2, the adjusted OR for hearing-aid use persistence was 0.46 (ci 0.43-0.48) in those with pre-existing dementia (vs. those remaining free of MCI and dementia).

ConclusionThe results indicate substantial effects from both causal pathways. Research studying protective effects of hearing-aid use against dementia needs to account for this. Clinically, hearing devices and hearing care processes must be accessible and usable for all, regardless of their level of cognitive function.

labels: otolaryngology


sentences: Genome-wide association study of liver fat, iron, and extracellular fluid fraction in the UK Biobank Abdominal magnetic resonance imaging (MRI) represents a non-invasive approach allowing the extraction of clinically informative phenotypes. We developed an automated pipeline to segment liver pixels from abdominal MRI images and apply published models to approximate fat fraction, extracellular fluid fraction and iron content in 40,058 MRIs from the UK Biobank. We then conducted a genome-wide association of these traits using imputed variants (N=37,250 individuals, 11,914,698 variants) and exome sequence data (N=35,274 individuals, 8,287,315 variants). For liver fat we identified 8 novel loci in or near genes MARC1, GCKR, ADH1B, MTTP, TRIB1, GPAM, PNPLA2 and APOH. For liver iron we identified 1 novel locus between the genes ASNSD1 and SLC40A1, an iron transporter involved in hemochromatosis. For extracellular fluid fraction we identified 6 novel loci in or near genes AGMAT, NAT2, MRPL4-S1PR2, FADS1, ABO and HFE, with almost all having prior associations to obesity, liver, iron, or lipid traits.


sentences: Adaptive data-driven selection of sequences of biological and cognitive markers in clinical diagnosis of dementia Combining the right--potentially invasive and expensive, markers at the appropriate time is critical to obtain reliable yet economically sustainable decisions in the preclinical diagnosis of dementia. We propose a data-driven analytical framework to individualize the selection of prognostic biomarkers that balance accuracy, costs of opportunity due to delaying the decision, and cost of acquisition depending to prescribed cost parameters. We compared sequential and non-sequential decision strategies based on a linear mixed-effects classification model that integrates irregular, multi-variate longitudinal data. The framework was applied to separate participants that progress to Alzheimers disease from the ones that do not within a time interval of three years. As expected, the highest accuracy was obtained by combining all available data from 20.9 measurements per subject on average that were acquired over 4.8 years on average. The proposed sequential algorithm empirically outperformed alternative methods by having lowest costs for a range of tested cost parameters. With the default cost parameters, the sequential algorithm reached an accuracy of 0.84, specificity of 0.86, and sensitivity of 0.82 (0.89, 0.91, and 0.88 with all available data, respectively) while requiring only 2.9 measurements on average (86 percent less observations than all available data) and a time interval of half a year on average (89 percent shorter than all time points). Our sequential algorithms established the decision based on individualized sequences of measurements with reduced process costs compared to non-sequential classification strategies while maintaining competitive accuracy.

labels: health informatics


sentences: Addressing Social Determinants While Social Distancing: The Development of an Evidence-Based Social Needs Screening for a Telehealth Setting Effectively addressing social determinants of health in clinical care can be challenging, and screening for such social needs is often overlooked. The COVID-19 pandemic has exacerbated health disparities and the impacts of social determinants of health, increasing the importance of both effective screening and intervention to address social needs. In response, the student-run free clinics at Stanford University sought to meet this need amongst our patient population by developing an evidence-based social needs screening (SNS) and referral protocol and integrating it into our novel telehealth model. The new protocol was implemented significantly more consistently compared to our previous checklist-based SNS, and more need was identified amongst our patient population than with the checklist-based, pre-pandemic screen. The new screening and referral protocol facilitated comprehensive patient care that addresses the social determinants of health in the clinical setting by improving our ability to identify patient social needs and refer such patients to community organizations. In describing the development, design, and implementation of this SNS, we hope to provide an example strategy for addressing social determinants of health within a student-run free clinic setting, and to encourage other student-run clinics and/or free clinics to similarly expand locally relevant social needs services.


sentences:
Health workers Motivators to uptake of the Covid-19 vaccine at Iganga Hospital Eastern Uganda, and Mengo Hospital Kampala Uganda; A qualitative study Uganda continues extensive mobilization and administration of the Covid 19 vaccine to its people albeit some vaccine hesitancy with in the population. Amongst the health workers however, approximately 70% had received their first dose while 40% had received their second dose of the Covid-19 vaccine by September 2021 respectively. These figures represent a recognizable acceptance rate among health workers. Exploring motivators to vaccine uptake among health workers is vital for the governments general population vaccine rollout plan.

We conducted 12 focus group discussions and 20 in-depth interviews with health workers (vaccinated and unvaccinated) to understand motivators to vaccine acceptance in their own perspective in central and eastern Uganda. Reported motivators to vaccine acceptance included; risk susceptibility/protection, fear of death and/or cost of treatment and experiences of Covid related grief. Other were trust in the vaccine, call to government policy and vaccine success stories elsewhere, real or perceived benefits of vaccination and peer influence.

We recommend intensified dissemination of health worker tailor made tools/guides for information, education and communication about the Covid 19 vaccine. The tools need to emphasize the elicited themes/motivators. We also recommend use of peers who have taken up the vaccine and survived Covid-19 or got a mild form of the disease to elicit positive peer influence about the vaccine amongst health workers. The information dissemination and peer narratives could be done through the health workers social media platforms, union or association websites, personal statements, editorials or other media.


sentences:
A "Made-in-Canada" serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination OBJECTIVESAntibody testing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been instrumental in detecting previous exposures and analyzing vaccine-elicited immune responses. Here, we describe a scalable solution to detect and quantify SARS-CoV-2 antibodies, discriminate between natural infection- and vaccination-induced responses, and assess antibody-mediated inhibition of the spike-angiotensin converting enzyme 2 (ACE2) interaction.

METHODSWe developed methods and reagents to detect SARS-CoV-2 antibodies by enzyme-linked immunosorbent assay (ELISA). The main assays focus on the parallel detection of immunoglobulin (Ig)Gs against the spike trimer, its receptor binding domain (RBD), and nucleocapsid (N). We automated a surrogate neutralization (sn)ELISA that measures inhibition of ACE2-spike or -RBD interactions by antibodies. The assays were calibrated to a World Health Organization reference standard.

RESULTSOur single-point IgG-based ELISAs accurately distinguished non-infected and infected individuals. For seroprevalence assessment (in a non-vaccinated cohort), classifying a sample as positive if antibodies were detected for [≥] 2 of the 3 antigens provided the highest specificity. In vaccinated cohorts, increases in anti-spike and -RBD (but not -N) antibodies are observed. We present detailed protocols for serum/plasma or dried blood spots analysis performed manually and on automated platforms. The snELISA can be performed automatically at single points, increasing its scalability.

CONCLUSIONSMeasuring antibodies to three viral antigens and identify neutralizing antibodies capable of disrupting spike-ACE2 interactions in high-throughput enables large-scale analyses of humoral immune responses to SARS-CoV-2 infection and vaccination. The reagents are available to enable scaling up of standardized serological assays, permitting inter-laboratory data comparison and aggregation.


sentences: COVCOG 1: Factors predicting Cognitive Symptoms in Long COVID. A First Publication from the COVID and Cognition Study. Since its first emergence in December 2019, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has evolved into a global pandemic. Whilst often considered a respiratory disease, a large proportion of COVID-19 patients report neurological symptoms, and there is accumulating evidence for neural damage in some individuals, with recent studies suggesting loss of gray matter in multiple regions, particularly in the left hemisphere. There are a number of mechanisms by which COVID-19 infection may lead to neurological symptoms and structural and functional changes in the brain, and it is reasonable to expect that many of these may translate into cognitive problems. Indeed, cognitive problems are one of the most commonly reported symptoms in those suffering from "Long COVID"--the chronic illness following COVID-19 infection that affects between 10-25% of sufferers. The COVID and Cognition Study is a part cross-sectional, part longitudinal, study documenting and aiming to understand the cognitive problems in Long COVID. In this first paper from the study, we document the characteristics of our sample of 181 individuals who had suffered COVID-19 infection, and 185 who had not. We explore which factors may be predictive of ongoing symptoms and their severity, as well as conducting an in-depth analysis of symptom profiles. Finally, we explore which factors predict the presence and severity of cognitive symptoms, both throughout the ongoing illness and at the time of testing. The main finding from this first analysis is that that severity of initial illness is a significant predictor of the presence and severity of ongoing symptoms, and that some symptoms during the acute illness--particularly limb weakness--may be more common in those that have more severe ongoing symptoms. Symptom profiles can be well described in terms of 5 or 6 factors, reflecting the variety of this highly heterogenous condition suffered by the individual. Specifically, we found that neurological and fatigue symptoms during the initial illness, and that neurological, gastro-intestinal, and cardiopulmonary symptoms during the ongoing illness, predicted experience of cognitive symptoms.


sentences:
Molecular epidemiology of HIV-1 in Oryol Oblast, Russia The HIV/AIDS epidemic in Russia is growing, with approximately 100,000 people infected annually. Molecular epidemiology can provide insight on the structure and dynamics of the epidemic. However, its applicability in Russia is limited by the weakness of genetic surveillance, as viral genetic data is only available for <1% of cases. Here, we provide a detailed description of the HIV-1 epidemic for one geographic region of Russia, Oryol Oblast, by collecting and sequencing viral samples from about a third of its HIV-positive population. We identify multiple introductions of HIV-1 into Oryol Oblast, resulting in 82 transmission lineages that together comprise 66% of the samples. Most introductions are of subtype A, the predominant HIV-1 subtype in Russia, followed by CRF63 and subtype B. Bayesian analysis estimates the effective reproduction number Re for subtype A at 2.8 [1.7-4.4], in line with a growing epidemic. The frequency of CRF63 has been growing more rapidly, with the median Re of 11.8 [4.6-28.7], in agreement with recent reports of this variant rising in frequency in some regions of Russia. In contrast to the patterns described previously in European and North American countries, we see no overrepresentation of males in transmission lineages; meanwhile, injecting drug users are overrepresented in transmission lineages. This likely reflects the structure of the HIV-1 epidemic in Russia dominated by heterosexual and, to smaller extent, IDU transmission. Samples attributed to MSM transmission are associated with subtype B and are less prevalent than expected from the male-to-female ratio for this subtype, suggesting underreporting of this transmission route. Together, our results provide a high-resolution description of the HIV-1 epidemic in Oryol Oblast, Russia, characterized by frequent interregional transmission, rapid growth of the epidemic and rapid displacement of subtype A with the recombinant CRF63 variant.

Author SummaryIn 2017, Russia registered 138,843 new HIV-1 infections, which is nearly 5 times that of the second-highest European country. Meanwhile, genetic surveillance of HIV-1 in Russia is low, with only <1% of all HIV-positive samples sequenced. Here, we characterize the HIV-1 epidemic in Oryol Oblast, a region of Russia with an HIV-positive population of 2,157 as of 2019, by collecting viral genetic data covering a third of this population. We show that HIV-1 has been introduced into the region hundreds of times over the last 25 years, with many of the introductions resulting in sustained transmission within the region. By studying the branching patterns of the viral evolutionary trees, we reveal a persistently growing epidemic. A rapidly growing transmission cluster is associated with the CRF63 recombinant variant which has been spreading rapidly through the population of injecting drug users since its introduction around 2014. By analysing the subtype B which is characteristic of transmission between men who have sex with men (MSM), we show that the MSM transmission route is underreported. To our knowledge, this study is the most detailed description of the HIV-1 epidemic in a region of Russia.


sentences:
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort - EPICOV BackgroundWe aimed to study whether social patterns of exposure to SARS-CoV-2 infection changed in France throughout the year 2020, in light to the easing of social contact restrictions.

MethodsA population-based cohort of individuals aged 15 years or over was randomly selected from the national tax register to collect socio-economic data, migration history, and living conditions in May and November 2020. Home self-sampling on dried blood was proposed to a 10% random subsample in May and to all in November. A positive anti-SARS-CoV-2 ELISA IgG result against the virus spike protein (ELISA-S) was the primary outcome. The design, including sampling and post-stratification weights, was taken into account in univariate and multivariate analyses.

ResultsOf the 134,391 participants in May, 107,759 completed the second questionnaire in November, and respectively 12,114 and 63,524 were tested. The national ELISA-S seroprevalence was 4.5% [95%CI: 4.0%-5.1%] in May and 6.2% [5.9%-6.6%] in November. It increased markedly in 18-24-year-old population from 4.8% to 10.0%, and among second-generation immigrants from outside Europe from 5.9% to 14.4%. This group remained strongly associated with seropositivity in November, after controlling for any contextual or individual variables, with an adjusted OR of 2.1 [1.7-2.7], compared to the majority population. In both periods, seroprevalence remained higher in healthcare professions than in other occupations.

ConclusionThe risk of Covid-19 infection increased among young people and second-generation migrants between the first and second epidemic waves, in a context of less strict social restrictions, which seems to have reinforced territorialized socialization among peers.

labels: public and global health


sentences: Early visual processing as a marker of disease, not vulnerability: Event-related potential (ERP) evidence from 22q11.2 deletion syndrome, a population at high risk for schizophrenia We investigated visual processing in 22q11.2 deletion syndrome (22q11.2DS), a condition characterized by an increased risk for schizophrenia. Visual processing differences have been described in schizophrenia but remain understudied early in the disease course. Electrophysiology was recorded during a visual adaptation task with different interstimulus intervals to investigate visual processing and adaptation in 22q11.2DS (with (22q+) and without (22q-) psychotic symptoms), compared to control and idiopathic schizophrenia groups. Analyses focused on early windows of visual processing. While increased amplitudes were observed in 22q11.2DS in an earlier time window (90-140 ms), decreased responses were seen later (165-205 ms) in schizophrenia and 22q+. 22q11.2DS, and particularly 22q-, presented increased adaptation effects. We argue that while amplitude and adaptation in the earlier time window may reflect specific neurogenetic aspects associated with a deletion in chromosome 22, amplitude in the later window may be a marker of the presence of psychosis and/or of its chronicity/severity.

labels: psychiatry and clinical psychology